WO2011139246A8 - Topical or injectable composition comprising humic acid salts and polyvinylpyrrolidone for the treatment of skin diseases - Google Patents

Topical or injectable composition comprising humic acid salts and polyvinylpyrrolidone for the treatment of skin diseases Download PDF

Info

Publication number
WO2011139246A8
WO2011139246A8 PCT/TR2011/000100 TR2011000100W WO2011139246A8 WO 2011139246 A8 WO2011139246 A8 WO 2011139246A8 TR 2011000100 W TR2011000100 W TR 2011000100W WO 2011139246 A8 WO2011139246 A8 WO 2011139246A8
Authority
WO
WIPO (PCT)
Prior art keywords
polyvinylpyrrolidone
humic acid
topical
skin diseases
treatment
Prior art date
Application number
PCT/TR2011/000100
Other languages
French (fr)
Other versions
WO2011139246A1 (en
WO2011139246A9 (en
WO2011139246A4 (en
Inventor
Mümin DIZMAN
Original Assignee
Dizman Muemin
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Dizman Muemin filed Critical Dizman Muemin
Publication of WO2011139246A1 publication Critical patent/WO2011139246A1/en
Publication of WO2011139246A8 publication Critical patent/WO2011139246A8/en
Publication of WO2011139246A9 publication Critical patent/WO2011139246A9/en
Publication of WO2011139246A4 publication Critical patent/WO2011139246A4/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/32—Macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. carbomers, poly(meth)acrylates, or polyvinyl pyrrolidone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/74—Synthetic polymeric materials
    • A61K31/785—Polymers containing nitrogen
    • A61K31/787—Polymers containing nitrogen containing heterocyclic rings having nitrogen as a ring hetero atom
    • A61K31/79—Polymers of vinyl pyrrolidone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/02—Medicinal preparations containing materials or reaction products thereof with undetermined constitution from inanimate materials
    • A61K35/10—Peat; Amber; Turf; Humus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/49—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/92—Oils, fats or waxes; Derivatives thereof, e.g. hydrogenation products thereof
    • A61K8/922—Oils, fats or waxes; Derivatives thereof, e.g. hydrogenation products thereof of vegetable origin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0014—Skin, i.e. galenical aspects of topical compositions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • A61Q19/08—Anti-ageing preparations
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q5/00—Preparations for care of the hair
    • A61Q5/006—Antidandruff preparations
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Epidemiology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Dermatology (AREA)
  • Birds (AREA)
  • Gerontology & Geriatric Medicine (AREA)
  • Inorganic Chemistry (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)

Abstract

An agent containing the mixture of humic acid and its salts with polyvinylpyrrolidone and natural herbal oils provides a cure of pilonidal sinus or dermis/epidermis diseases by applying to skin in topical or injectable form without any need of surgical operation. This therapy method is a new technique in pilonidal sinus or skin diseases. The method guarantees patients to cure with the logic of "healing of an open wound" with low recurrence probability and without affecting the daily life standards. The result product is formed by humic acid -polyvinylpyrrolidone (HAP) about 10: 1 ratio, mixed by 150 d/d in a mixer, heated to max. 90°C, adjusted by pH 6.0 to 12.0 at 2-24 hours.
PCT/TR2011/000100 2010-05-06 2011-05-06 Topical or injectable composition comprising humic acid salts and polyvinylpyrrolidone for the treatment of skin diseases WO2011139246A1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
TR2010/03579A TR201003579A2 (en) 2010-05-06 2010-05-06 Treatment of upper and lower skin diseases with a topical and injectable wound healing agent.
TR2010/03579 2010-05-06

Publications (4)

Publication Number Publication Date
WO2011139246A1 WO2011139246A1 (en) 2011-11-10
WO2011139246A8 true WO2011139246A8 (en) 2012-05-31
WO2011139246A9 WO2011139246A9 (en) 2013-02-07
WO2011139246A4 WO2011139246A4 (en) 2013-04-04

Family

ID=42795460

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/TR2011/000100 WO2011139246A1 (en) 2010-05-06 2011-05-06 Topical or injectable composition comprising humic acid salts and polyvinylpyrrolidone for the treatment of skin diseases

Country Status (2)

Country Link
TR (1) TR201003579A2 (en)
WO (1) WO2011139246A1 (en)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US10183047B2 (en) 2014-05-21 2019-01-22 Natreon, Inc. Chromium-containing compositions in combination with Phyllanthus emblica and shilajit having synergistic effects for improving endothelial function and cardiovascular health
ES2886555T3 (en) 2014-10-02 2021-12-20 Natreon Inc Promotion of muscle building and repair and treatment of disorders related to collagen and relevant proteins through the use of Shilajit
US9820953B2 (en) * 2016-02-26 2017-11-21 Omni Bioceutical Innovations, Inc. Compositions of bioactive fulvate fractions and uses thereof

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3615780A (en) 1969-05-28 1971-10-26 Itt Rayonier Inc Silicate-catalyzed chemical grouting compositions
DE3707909A1 (en) 1987-03-12 1988-09-22 Ruetgerswerke Ag LOW MOLECULAR ALKALIHUMINATES, METHOD FOR THE PRODUCTION AND USE THEREOF
DE4134384A1 (en) * 1991-10-17 1993-04-22 Ruetgerswerke Ag MODIFIED HUMINATES, METHOD FOR THEIR PRODUCTION AND USE
EP0670726B1 (en) 1993-09-24 2002-03-20 Maurizio Zanetti Treatment of hiv infection with humic acid
US5626881A (en) 1995-05-16 1997-05-06 Menefee Mining Corporation Humate dietary supplement
US6534049B2 (en) 1997-02-10 2003-03-18 Laub Biochemicals Corp. Synthetic soil-extract materials and medicaments for human immunodeficiency viruses based thereon
US6524567B2 (en) 1997-02-10 2003-02-25 Laub Biochemicals Corp. Synthetic soil-extract materials and medicaments for hemorrhagic fever viruses based thereon
US5945446A (en) 1997-02-10 1999-08-31 Laubc Biochemicals, Corporation Process for preparing synthetic soil-extract materials and medicaments based thereon
US6576229B2 (en) 1997-02-10 2003-06-10 Laub Biochemicals Corp. Synthetic soil-extract materials and medicaments for influenza viruses based thereon
CN1156274C (en) * 2002-03-28 2004-07-07 中国科学院新疆理化技术研究所 Medicinal ointment containing zinc conjugated linoleate and sodium humate
US7067155B2 (en) 2003-01-03 2006-06-27 Tbni, Inc. Anti-inflammatory humate compositions and methods of use thereof
JP5383963B2 (en) * 2005-03-29 2014-01-08 エンザイム株式会社 Humus, humus extract and moisturizing liquid, and their production and use
TR200700973A2 (en) * 2007-02-20 2007-10-22 Di̇zman Mümi̇n Treatment of pilonidal sinus with polyphenols.
WO2009158667A2 (en) * 2008-06-27 2009-12-30 Comgenrx, Inc. Povidone compositions for wound healing

Also Published As

Publication number Publication date
WO2011139246A1 (en) 2011-11-10
TR201003579A2 (en) 2010-07-21
WO2011139246A9 (en) 2013-02-07
WO2011139246A4 (en) 2013-04-04

Similar Documents

Publication Publication Date Title
WO2019199861A3 (en) Hemp extract for treatment of pain in animals
EP3501546A3 (en) Cysteine drug conjugates and use of same
CN101791283B (en) Cosmetic capable of eliminating striae gravidarum and scars
SG179027A1 (en) Dosage regimen for administering an epcamxcd3 bispecific antibody
NZ586302A (en) Pre-surgical treatment using brimonidine applied topically to reduce bleeding or bruising
WO2009022338A3 (en) Erythropoietin and fibronectin compositions for therapeutic and cosmetic applications
WO2014191738A8 (en) Degradable haemostat composition
RU2013132566A (en) THERAPEUTIC AGAINST HERNIASIS
WO2011139246A9 (en) Topical or injectable composition comprising humic acid salts and polyvinylpyrrolidone for the treatment of skin diseases
TW200724150A (en) Plant extracts for treating skin disorders and enhancing healing of wounds for diabetics patients
WO2005092303A3 (en) Combination therapy with azd2171 and 5-fu and/or cpt-11
WO2013065078A3 (en) Topical preparation containing ngf for inducing skin pigmentation and for the treatment of cutaneous dyschromias and vitiligo
CN103417750B (en) Ointment that a kind for the treatment of is chapped and preparation method thereof
AU2015268649B2 (en) A composition and method of applying same & a composition that assists healing burns and wounds with antibacterial and anti-fungal actions
CN104474577A (en) Laser beatifying postoperation dressing and preparation method thereof
CN103520206B (en) External medicinal composition for treating dermatosis and preparation method for external medicinal composition
WO2010111108A3 (en) Compositions and methods for the treatment of wounds
CN203208213U (en) Wound suturing adhesive plaster
WO2009134396A3 (en) Use of corticotropin-releasing factor for the treatment of cancer
Kumar et al. Vitamin C premedication reduces Postoperative rescue analgesic requirement after laparoscopic surgeries
CN103800369A (en) Ointment for treating verruca
CN103040957B (en) Hair growth-promoting solution
MX2012002190A (en) Herbal pharmaceutical formulation from cydonia oblonga used as analgesic, anti-inflammatory, antiseptic and mucoprotector, process for the preparation and application thereof.
CN101428042A (en) Guereza recovery plaster
MX343284B (en) Aqueous extract of ageratina pichinchensis and use thereof in the treatment of wound healing.

Legal Events

Date Code Title Description
121 Ep: the epo has been informed by wipo that ep was designated in this application

Ref document number: 11743893

Country of ref document: EP

Kind code of ref document: A1

NENP Non-entry into the national phase

Ref country code: DE

122 Ep: pct application non-entry in european phase

Ref document number: 11743893

Country of ref document: EP

Kind code of ref document: A1